ClinicalTrials.Veeva

Menu

Transcranial Electrical Stimulation in Multiple Sclerosis (TEMS)

U

Universitair Ziekenhuis Brussel

Status

Not yet enrolling

Conditions

Multiple Sclerosis

Treatments

Device: transcranial Direct Current Stimulation

Study type

Interventional

Funder types

Other

Identifiers

NCT06966128
FWOAL1107 (Other Grant/Funding Number)
24378_TEMS

Details and patient eligibility

About

First the investigators will examine if the blood flow in the brain is different in patients with Multiple Sclerosis compared to healthy volunteers.

HOW?

  • The blood flow of the subjects is imaged by use of a special MRI-technique.

Secondly, the investigators will examine if the blood flow can determine disease progression.

HOW? - Multiple Sclerosis patients are asked for a follow-up visit after two years.

The main goal is to understand the effect of transcranial Direct Current Stimulation (tDCS) on the cerebral blood flow.

  • Does tDCS result in a different blood flow, in which brain regions?
  • Is there a difference between healthy volunteers and Multiple Sclerosis patients?

HOW?

  • Participants get two session of tDCS. Before, during and after stimulation MRI scans are performed.

Full description

Comparison of CBF between healthy volunteers and MS patients:

  • Arterial spin labelling (ASL) is used to investigate cerebral blood flow in patients with MS and healthy volunteers.

The effect of transcranial direct current stimulation (tDCS) on cerebral blood flow:

  • ASL scans are performed before-, during-, and after tDCS
  • Each subject will receive active and sham tDCS (seperated by at least two days) (cross-over design).

Follow-up visit:

  • After two years, patients with MS are re-invited.
  • This visit will include a new neuropsychological evaluation, blood sampling and additional brain scans.

Enrollment

100 estimated patients

Sex

All

Ages

18 to 60 years old

Volunteers

Accepts Healthy Volunteers

Inclusion and exclusion criteria

Inclusion criteria - MS patient

  • EDSS ≥ 2 and EDSS ≤ 6.5
  • Age ≥ 18

Exclusion criteria - MS patient

  • EDSS > 6.5
  • Incompatibility with MRI
  • Relapse within three months before the study and its use of corticosteroids
  • Disabling concomitant neuropsychiatric diseases
  • Chance of pregnancy, breastfeeding
  • Contraindications to tDCS

Inclusion criteria - Healthy Volunteer

• Age ≥ 18

Exclusion criteria - Healthy Volunteer

  • Incompatibility with MRI
  • Disabling concomitant neuropsychiatric diseases
  • Chance of pregnancy, breastfeeding
  • Contraindications to tDCS

Trial design

Primary purpose

Basic Science

Allocation

Randomized

Interventional model

Crossover Assignment

Masking

Triple Blind

100 participants in 2 patient groups

Sham-first tDCS
Other group
Description:
The sham-first group will receive: Sham stimulation in visit 1, Active stimulation in visit 2
Treatment:
Device: transcranial Direct Current Stimulation
Active-first tDCS
Other group
Description:
The active-first group will receive: Active stimulation in visit 1, Sham stimulation in visit 2
Treatment:
Device: transcranial Direct Current Stimulation

Trial contacts and locations

2

Loading...

Central trial contact

Kristien Cool, Master in Biomedical Sciences

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems